Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS Sarepta Therapeutics The crisis over Sarepta’s Duchenne therapy is a mess. But the lesson is clear statnews.com FDA probes death of patient on Sarepta’s Elevidys, partner Roche says death unrelated to therapy Reuters ‘We will crack gene therapy’: Elevidys fallout doesn’t dent Roche’s hopes for modality Fierce Biotech FDA weighs new study requirements for Sarepta to confirm …
Read More »